19-52300425-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144684.4(ZNF480):c.13G>A(p.Glu5Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,612,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144684.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF480 | NM_144684.4 | c.13G>A | p.Glu5Lys | missense_variant | 2/5 | ENST00000595962.6 | NP_653285.2 | |
ZNF480 | NM_001297624.2 | c.13G>A | p.Glu5Lys | missense_variant | 2/4 | NP_001284553.1 | ||
ZNF480 | NM_001297625.2 | c.-92G>A | 5_prime_UTR_variant | 2/4 | NP_001284554.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF480 | ENST00000595962.6 | c.13G>A | p.Glu5Lys | missense_variant | 2/5 | 1 | NM_144684.4 | ENSP00000471754.1 | ||
ZNF480 | ENST00000468240.6 | n.13G>A | non_coding_transcript_exon_variant | 2/6 | 2 | ENSP00000417424.1 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150828Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251318Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135836
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461148Hom.: 0 Cov.: 33 AF XY: 0.0000179 AC XY: 13AN XY: 726924
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150946Hom.: 0 Cov.: 32 AF XY: 0.0000408 AC XY: 3AN XY: 73564
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2022 | The c.13G>A (p.E5K) alteration is located in exon 2 (coding exon 1) of the ZNF480 gene. This alteration results from a G to A substitution at nucleotide position 13, causing the glutamic acid (E) at amino acid position 5 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at